Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.8600
+0.0300 (3.61%)
Jan 7, 2026, 4:00 PM EST - Market closed

Revenue by Product

Millions AUD. Fiscal year is Jul - Jun.
Year Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2003 - 2019
Hyper-immune Products
4.90M
Log In
Log In
Log In
Log In
Upgrade
Hyper-immune Products Growth
171.67%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions AUD. Fiscal year is Jul - Jun.
Year Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2003 - 2019
Australia
3.75M
Log In
Log In
Log In
Log In
Upgrade
Australia Growth
222.77%
Log In
Log In
Log In
Log In
Upgrade
United States
1.08M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
67.33%
Log In
Log In
Log In
Log In
Upgrade
Canada
80.89K
Log In
Log In
Log In
Log In
Upgrade
Canada Growth
6635.05%
Log In
Log In
Log In
Log In
Upgrade